Research & Innovation Related Content

Megan Warrender, Assistant Editor at Open Access Government, discusses research and innovation in Europe, and why in a post COVID-19 world, science is more important than ever.

Open Access Government investigates Portugal’s current strategies for improving research and innovation post COVID-19, and finds that knowledge and education are key.

Hannah Deacon, co-founder of Maple Tree Consultancy, explores how COVID is elevating and shaping the medical application of CBD.

Professor Sandra Carvalho, University of Minho, Department of Physics, discusses the emergence of surface functionalization as a strategy in biotech and health.

We look at the problems that occur when climate science is translated into policy, and investigate how these problems still happen.

Here, Bengt Fellbe discusses the progress of investments and research projects.

Here, Professor Gerald Misinzo and Professor Mark Rweyemamu discuss the potential of the RSIF-PASET Programme.

In the digital age, it is vital to recognise cybersecurity as a real threat, and EHJ & SJ Consultancy Ltd are providing digital solutions to match our world of accelerated digital transformation.

Dr Dawn Martin-Hill and Dr Christine Wekerle from McMaster University highlight Indigenous youth resilience research, including comment on what water teaches us.

Dr David Carroll from CU Aerospace LLC says that there are advantages to nano-satellites and the Space 2.0 environment, but they exacerbate the problem of orbital debris.

Here, we discuss how some political barriers create a significant challenge for those pushing to reduce transport emissions.

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.

Monique Groenewold discusses how modern innovation requires regulatory preparedness in risk governance, especially for nanotechnology.

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.

Jim Siegrist from the Office of Science at the U.S. Department of Energy, charts how future machines will explore new frontiers in particle physics.

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.

Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.

Karen Moor and Marlies Wijsenbeek discuss how pulmonary fibrosis patients can be helped by the new possibilities of eHealth apps.

John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.

Researchers have discovered a protein in plant roots that could improve the tolerance of crops to climate change and reduce the need for chemical fertilisers.